Inflammatory factors and immunoglobulins alterations in subjects with type 2 diabetes mellitus treated with squalene

Authors

  • Danik Martirosyan PhD, Functional Food Center/Functional Food Institute
  • Mohammad Reza Ashoori Department of Laboratory Sciences, School of Allied Medical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran
  • Afsaneh Seyed Mikaeili Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences and Technology, Islamic Azad University, Pharmaceutical Sciences Branch, Tehran, Iran
  • Shaghayegh Pezeshki PhD, Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Anna Serani Georgia Institute of Technology, Atlanta, Georgia, USA
  • Michelle Lee Cornell University, Ithaca, New York, USA
  • Hossein Mirmiranpour Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.31989/ffs.v2i8.979

Abstract

Background: Squalene is a 30-carbon (as a polyunsaturated triterpene) compound that has been suggested to have several benefits. In recent years, its anti-diabetic, anti-inflammatory and antioxidant effects have been studied.

Objective: The aim of this study was to investigate the effect of different doses of squalene on different days on the changes in the levels of inflammatory cytokines and antibodies in people with type 2 diabetes and then compare it.

Methods: In this study, 4 groups with type 2 diabetes mellitus and 1 control group were selected. 4 groups with type 2 diabetes mellitus were divided into 1 diabetic group without squalene consumption for 84 days and 3 diabetic groups treated with squalene in doses of 200, 400 and 600 mg, respectively for 84 days. The levels of Interleukin-1 alpha, Interleukin-1 beta, Interleukin-4, immunoglobulin A, immunoglobulin G, immunoglobulin M, and as well as the glucose of all participants were measured by Enzyme-linked immunosorbent assay method. 

Results: On days 14 and 28, a statistically significant difference (P value < 0.05) was observed in the level of Interleukin-1 alpha and Interleukin-4 in groups 3, 4 and 5 compared to group 2. This significant difference in the levels of interleukin-1 beta and immunoglobulin A was observed only on days 56 and 84. No statistically significant difference (P value > 0.05) was observed in the levels of immunoglobulins G, M, and glucose during the consumption of squalene between the groups.

Conclusions: According to the time and dose, squalene can be effective in reducing inflammatory factors and increasing immunoglobulin A. However, additional studies are needed for the action mechanism and the effect of squalene.

Keywords: squalene, triterpene, interleukin, immunoglobulin, diabetes mellitus

Downloads

Published

2022-08-30

Issue

Vol. 2 No. 8 (2022): August 2022

Section

Research Articles

License

Authors retain the copyright of their articles and grant the Functional Food Center (FFC) and its journals the right of first publication under the terms of the Creative Commons Attribution 4.0 International License.

This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited. Authors may post and share their published work freely, provided that the original publication in this journal is acknowledged.

By submitting to this journal, authors confirm that their manuscripts are original, not under consideration elsewhere, and that they hold the necessary rights to grant this license. The Functional Food Center encourages open scientific exchange and allows derivative and extended works, provided attribution to the original publication is maintained.